aged 0 4 0 4 B-age
40 5 7 5 7 B-lower_bound
- 7 8 7 8 O
49 8 10 8 10 B-upper_bound
years 11 16 11 16 I-upper_bound

aromatase 0 9 17 26 B-treatment
inhibitors 10 20 27 37 I-treatment
for 21 24 38 41 O
breast 25 31 42 48 B-cancer
cancer 32 38 49 55 I-cancer
prevention 39 49 56 66 O

read 0 4 67 71 B-language_fluency
and 5 8 72 75 I-language_fluency
speak 9 14 76 81 I-language_fluency
English 15 22 82 89 I-language_fluency

scheduled 0 9 90 99 O
for 10 13 100 103 O
a 14 15 104 105 O
routine 16 23 106 113 O
visit 24 29 114 119 O
or 30 32 120 122 O
physical 33 41 123 131 O
examination 42 53 132 143 O
with 54 58 144 148 O
a 59 60 149 150 O
non 61 64 151 154 O
- 64 65 154 155 O
resident 65 73 155 163 O
PCP 74 77 164 167 O
in 78 80 168 170 O
the 81 84 171 174 O
next 85 89 175 179 B-lower_bound
4 90 91 180 181 I-lower_bound
- 91 92 181 182 O
12 92 94 182 184 B-upper_bound
weeks 95 100 185 190 I-upper_bound
at 101 103 191 193 O
HealthCare 104 114 194 204 O
Associates 115 125 205 215 O
( 126 127 216 217 O
HCA 127 130 217 220 O
, 130 131 220 221 O
BIDMC 132 137 222 227 O
's 137 139 227 229 O
outpatient 140 150 230 240 O
primary 151 158 241 248 O
care 159 163 249 253 O
practice 164 172 254 262 O
) 172 173 262 263 O

women 0 5 264 269 B-gender

women 0 5 270 275 B-gender
already 6 13 276 283 O
receiving 14 23 284 293 O
screening 24 33 294 303 O
breast 34 40 304 310 O
MRIs 41 45 311 315 O

women 0 5 316 321 B-gender
who 6 9 322 325 O
had 10 13 326 329 O
or 14 16 330 332 O
will 17 21 333 337 O
have 22 26 338 342 O
a 27 28 343 344 O
mammogram 29 38 345 354 B-treatment
within 39 45 355 361 O
6 46 47 362 363 B-upper_bound
months 48 54 364 370 I-upper_bound
of 55 57 371 373 O
their 58 63 374 379 O
PCP 64 67 380 383 O
visit 68 73 384 389 O

women 0 5 390 395 B-gender
who 6 9 396 399 O
have 10 14 400 404 O
been 15 19 405 409 O
referred 20 28 410 418 O
to 29 31 419 421 O
genetic 32 39 422 429 O
counseling 40 50 430 440 O

women 0 5 441 446 B-gender
who 6 9 447 450 O
have 10 14 451 455 O
taken 15 20 456 461 O
or 21 23 462 464 O
are 24 27 465 468 O
taking 28 34 469 475 O
tamoxifen 35 44 476 485 B-treatment

women 0 5 486 491 B-gender
with 6 10 492 496 O
a 11 12 497 498 O
history 13 20 499 506 O
of 21 23 507 509 O
breast 24 30 510 516 B-cancer
cancer 31 37 517 523 I-cancer
or 38 40 524 526 O
a 41 42 527 528 O
BRCA 43 47 529 533 B-cancer
mutation 48 56 534 542 I-cancer

women 0 5 543 548 B-gender
with 6 10 549 553 O
a 11 12 554 555 O
history 13 20 556 563 O
of 21 23 564 566 O
breast 24 30 567 573 B-treatment
enlargement 31 42 574 585 I-treatment
or 43 45 586 588 I-treatment
reduction 46 55 589 598 I-treatment

